20
Participants
Start Date
February 27, 2019
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Envarsus XR
The Envarsus XR® drug will be administered to study participants once daily, orally. The dosage can be 0.75 mg, 1 mg or 4 mg. The tacrolimus whole blood trough concentrations will be monitored and titrate Envarsus XR® dosage to achieve target whole blood trough concentration.
RECRUITING
University of Wisconsin, Madison
Collaborators (1)
Veloxis Pharmaceuticals
INDUSTRY
University of Wisconsin, Madison
OTHER